Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Aktiesnakken
  4. Aktiesnakken — Juni 2016

Aktiesnakken — Juni 2016

Planlagt Fastgjort Låst Flyttet Aktiesnakken
485 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • doodhaD Offline
    doodhaD Offline
    doodha
    wrote on sidst redigeret af
    #206

    Så er der overvægt af Brexit-tilhængere: https://ig.ft.com/sites/brexit-polling/

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #207

      God morgen. 🙂

      1 Reply Last reply
      0
      • P Offline
        P Offline
        pauly
        wrote on sidst redigeret af
        #208

        god morgen

        1 Reply Last reply
        0
        • M Offline
          M Offline
          MUFC_Oberanven
          wrote on sidst redigeret af
          #209

          LinkedIn op 50% i premarket: Microsoft to acquire LinkedIn - PR Newswire
          13-Jun-2016 15:22:06
          For best results when printing this announcement, please click on link below: http://pdf.reuters.com/htmlnews/htmlnews.asp...

          Microsoft to acquire LinkedIn Deal brings together the world's leading professional cloud with the world's leading professional network. PR Newswire

          1 Reply Last reply
          0
          • P Offline
            P Offline
            pauly
            wrote on sidst redigeret af
            #210

            ærgeligt man ikke har dem

            1 Reply Last reply
            0
            • O Offline
              O Offline
              OHW
              wrote on sidst redigeret af
              #211

              Er der nogen steder man kan følge Novo's præsentation??

              1 Reply Last reply
              0
              • H Offline
                H Offline
                henrik48
                wrote on sidst redigeret af
                #212

                Der må vel snart være nyt om Novo fra New Orleans ??

                1 Reply Last reply
                0
                • CeletusC Offline
                  CeletusC Offline
                  Celetus
                  wrote on sidst redigeret af
                  #213

                  CV death reduced by 22%

                  1 Reply Last reply
                  0
                  • CeletusC Offline
                    CeletusC Offline
                    Celetus
                    wrote on sidst redigeret af
                    #214

                    all cause death by 15% and 3 point MACE by 13%

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      MUFC_Oberanven
                      wrote on sidst redigeret af
                      #215

                      Via twitter dukker fantatiske Novo nyheder op 🙂

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        MUFC_Oberanven
                        wrote on sidst redigeret af
                        #216

                        5% op i morgen på Novo

                        1 Reply Last reply
                        0
                        • CeletusC Offline
                          CeletusC Offline
                          Celetus
                          wrote on sidst redigeret af
                          #217

                          Enig.

                          1 Reply Last reply
                          0
                          • CeletusC Offline
                            CeletusC Offline
                            Celetus
                            wrote on sidst redigeret af
                            #218

                            imponerende produkt

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              MUFC_Oberanven
                              wrote on sidst redigeret af
                              #219

                              New Orleans, US, 13 June 2016 – Novo Nordisk today announced that Victoza® (liraglutide) significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke by 13% vs placebo (95% confidence interval [CI]: 0.78; 0.97, p=0.01), when added to standard of care in 9,340 adults with type 2 diabetes at high CV risk. The main results of the LEADER trial were presented today at the American Diabetes Association

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                MUFC_Oberanven
                                wrote on sidst redigeret af
                                #220

                                There was a significant 22% reduction in cardiovascular death with Victoza® treatment vs placebo (95% CI: 0.66; 0.93, p=0.007) and reductions in non-fatal myocardial infarction (HR=0.88, 95% CI: 0.75; 1.03, p=0.11) and non-fatal stroke (HR=0.89, 95% CI: 0.72; 1.11, p=0.30).1, 2

                                1 Reply Last reply
                                0
                                • Den_FattigeD Offline
                                  Den_FattigeD Offline
                                  Den_Fattige
                                  wrote on sidst redigeret af
                                  #221

                                  Er det godt eller skide godt ??

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #222

                                    http://www.proinvestor.com/aktienyt/HUG2020216/Victoza®-viser-signifikant-reduktion-af-risikoen-for-alvorlige-kardiovaskulaere-haendelser-og-doed-hos-voksne-med-type-2-diabetes-i-LEADER-studiet

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      MUFC_Oberanven
                                      wrote on sidst redigeret af
                                      #223

                                      Åbenbart så er disse Victoza Data nok som forventet.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #224

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #225

                                          En god gennem omkring data på Victosa. http://www.proinvestor.com/investornyt/377774/novo-victoza-vaekker-laeger-og-diabetikere-til-live

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper